Abstract
A total of 32 patients with advanced non-small-cell lung cancer were treated with carboplatin (350 mg/m2, day 1) and vinorelbine (days 1 and 8) every 28 days. A response rate of 28% (95% confidence limits 12.5 – 43.7%) was observed. The activity of this combination was demonstrated in an outpatient setting with acceptable toxicity.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Received: 6 July 1995 / Accepted: 19 October 1995
Rights and permissions
About this article
Cite this article
Pronzato, P., Ghio, E., Losardo, P. et al. Carboplatin and vinorelbine in advanced non-small-cell lung cancer. Cancer Chemother Pharmacol 37, 610–612 (1996). https://doi.org/10.1007/s002800050436
Issue Date:
DOI: https://doi.org/10.1007/s002800050436